HER2 Support Group Forums - EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related event

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- General Cancer News (https://her2support.org/vbulletin/forumdisplay.php?f=45)

- - EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related event (https://her2support.org/vbulletin/showthread.php?t=50769)

News	07-15-2011 05:10 AM

EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related event

Amgen today announced that the European Commission (EC) has granted marketing authorization for XGEVA (denosumab) for the prevention of skeletal-related events (SREs) in adults with bone metastases from solid tumors.

More...

All times are GMT -7. The time now is 07:25 AM.